-
Ingredion (INGR) PT Lowered to $123 at BMO Capital
-
Ingredion appoints Patrick Kalotis as EVP Global Texture & Healthful Solutions
-
Ingredion agrees to sell majority stake in Rafhan Maize unit
-
Ingredion to sell majority stake in Pakistan affiliate to Nishat Group
-
UBS Reiterates Neutral Rating on Ingredion (INGR), Awaits Sustained Growth From THS Segment
-
Amyris and Ingredion (INGR) wind down RealSweet JV
-
Ingredion (INGR) Tops Q1 EPS by 56c; raises guidance
-
Ingredion (INGR) PT Lowered to $133 at BMO Capital Amid 'Policy Uncertainties'
-
Ingredion (INGR) PT Lowered to $150 at Stephens
-
Ingredion (INGR) PT Lowered to $167 at Oppenheimer
-
Ingredion (INGR) Invests $100M in Indianapolis Plant
-
Ingredion (INGR) Tops Q4 EPS by 10c
-
Ingredion (INGR) Appoints Mark Karns as VP Corporate Development and M&A
-
Icahn Enterprises L.P. (INGR) Tops Q3 EPS by 45c; offers guidance
-
Ingredion (INGR) PT Raised to $147 at Oppenheimer
-
Barclays Upgrades Ingredion (INGR) to Overweight
-
Ingredion (INGR) PT Raised to $128 at BMO Capital
-
Ingredion (INGR) PT Raised to $138 at Oppenheimer
-
Icahn Enterprises L.P. (INGR) Tops Q2 EPS by 35c, raises guidance

